Overview of Dr. Takeda
Dr. Koji Takeda is a thoracic surgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, NewYork-Presbyterian/Allen Hospital, and NewYork-Presbyterian/Lawrence Hospital. He received his medical degree from Osaka University Medical School and has been in practice 18 years. He is one of 143 doctors at New York-Presbyterian Hospital and one of 14 doctors at NewYork-Presbyterian/Allen Hospital who specialize in Thoracic Surgery. He also speaks multiple languages, including Japanese. He has more than 100 publications and over 500 citings.
Office
177 Ft. Washington Avenue
New York, NY 10032
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Thoracic Surgery, 2012
- Osaka University Medical SchoolClass of 1999
Certifications & Licensure
- NY State Medical License 2012 - 2026
- CT State Medical License 2021 - 2025
- NJ State Medical License 2022 - 2025
- IL State Medical License 2010 - 2012
Publications & Presentations
PubMed
- 1 citationsBridge to simultaneous heart-kidney transplantation via extracorporeal life support: National outcomes in the new heart allocation policy era.Iris Feng, Paul A Kurlansky, Yanling Zhao, Krushang Patel, Morgan K Moroi
The Journal of Heart and Lung Transplantation. 2025-01-01 - 2 citationsComparing 3-year survival and readmissions between HeartMate 3 and heart transplant as primary treatment for advanced heart failure.Michael Kirschner, Veli K Topkara, Jocelyn Sun, Paul Kurlansky, Yuji Kaku
The Journal of Thoracic and Cardiovascular Surgery. 2025-01-01 - Pre-operative pectoralis muscle area index is associated with biomarkers of inflammation and endotoxemia and predicts clinical outcomes after left ventricular assist d...Matthew R Carey, Annamaria Ladanyi, Mia Nishikawa, Abraham Bordon, Jay S Leb
Artificial Organs. 2024-12-01
Journal Articles
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019Farhana Latif, Maryjane A Farr, Kevin J Clerkin, Koji Takeda, Yoshifumi Naka, Susan Restaino, Gabriel Sayer, Nir Uriel, JAMA Cardiology
- VA‐ECMO for Cardiogenic Shock in the Contemporary Era of Heart Transplantation: Which Patients Should Be Urgently Transplanted?Yoshifumi Naka, Maryjane A Farr, Koji Takeda, Paolo Colombo, Hiroo Takayama, Arthur R Garan, Veli K Topkara, Clinical Transplantation
Authored Content
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
Press Mentions
- The Power of MedicineMay 17th, 2023
- Efficacy of Osimertinib plus Bevacizumab vs Osimertinib in Patients with EGFR T790M–Mutated Non–Small Cell Lung Cancer Previously Treated with Epidermal Growth Factor Receptor–Tyrosine Kinase InhibitorJanuary 7th, 2021
- Phase II Study of Nimotuzumab in Combination with Concurrent Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung CancerDecember 26th, 2020
- Join now to see all
Professional Memberships
- Member
Other Languages
- Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: